PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,954 | +629.4% | 177,125 | +1108.7% | 0.03% | +833.3% |
| Q2 2023 | $405 | -58.8% | 14,654 | -83.7% | 0.00% | -78.6% |
| Q4 2022 | $983 | -99.9% | 90,107 | -17.2% | 0.01% | +16.7% |
| Q3 2022 | $918,000 | +4.4% | 108,876 | -2.0% | 0.01% | +9.1% |
| Q2 2022 | $879,000 | +177.3% | 111,126 | +607.8% | 0.01% | +266.7% |
| Q4 2020 | $317,000 | -16.4% | 15,701 | -47.9% | 0.00% | -89.3% |
| Q1 2019 | $379,000 | +294.8% | 30,119 | +112.1% | 0.03% | +300.0% |
| Q4 2018 | $96,000 | – | 14,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 750,632 | $7,724,000 | 26.59% |
| BVF INC/IL | 2,617,967 | $26,939,000 | 2.37% |
| GREAT POINT PARTNERS LLC | 982,449 | $10,109,000 | 1.58% |
| Alambic Investment Management, L.P. | 65,128 | $670,000 | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,243,202 | $23,083,000 | 0.14% |
| ALGERT GLOBAL LLC | 44,477 | $458,000 | 0.10% |
| Monashee Investment Management LLC | 42,945 | $442,000 | 0.09% |
| Tekla Capital Management LLC | 219,042 | $2,254,000 | 0.08% |
| Spark Investment Management LLC | 138,800 | $1,428,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 187,653 | $1,904,000 | 0.04% |